PAM
ORIA

Panagora Asset Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Panagora Asset Management’s Portfolio ORIA Stock Details ORIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,480
Closed -$130K – 1761
2021
Q3 		$130K Buy
+13,480
New +$132K ﹤0.01% 1677

Other funds holding ORIA

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Panagora Asset Management's ORIA Position: Q4 2021 in Review

Panagora Asset Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q4 2021, closing a stake of 13,480 shares — an estimated $130K sold.

Panagora Asset Management first reported a position in ORIA in Q3 2021 and held it in 1 quarter. The position peaked at $130K in Q3 2021. 35 funds tracked by Wall St. Rank hold ORIA as of Q4 2021.

  • Panagora Asset Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q4 2021 after selling out during the quarter.
  • Panagora Asset Management sold 13,480 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q4 2021, an estimated $130K.
  • Panagora Asset Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 1 quarter.
  • Panagora Asset Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $130K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q4 2021.

Based on Panagora Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.